IFNA1 and hepatocellular carcinoma: Higher levels of hepatitis B virus (HBV) DNA are associated with an increased risk for hepatocellular carcinoma (HCC) and cirrhosis.1 In addition, available evidence suggests that CHB patients with HVL are less likely to respond to interferon (IFN)-based regimens than those with lower viral load.